Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

Recruiting

Trial locations(1 site)

United States

Octapharma Research Site, Boston, Massachusetts

Sponsor

Octapharma

Enrollment target

~3,574 participants

Started

February 2025

Primary completion

December 2031

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2025.

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Patrick Murphy

Octapharma